Castration Resistant Prostatic Neoplasms Recruiting Phase 1 / 2 Trials for Enzalutamide (DB08899)

Also known as: Prostate Neoplasms, Castration-resistant / Castration-Resistant Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant

DBCOND0129140 (Castration Resistant Prostatic Neoplasms)Recruiting1 / 2 IdentifierTitlePurposeDrugs
NCT04381832Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate CancerTreatment
NCT05252390NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsTreatment